Title: Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia
Abstract: Journal of Medical VirologyVolume 93, Issue 1 p. 32-34 LETTER TO THE EDITOR Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia Maria Mazzitelli, Corresponding Author Maria Mazzitelli [email protected] orcid.org/0000-0003-0263-0703 Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy Correspondence Maria Mazzitelli, MD, Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University, Viale Europa 22, 88100 Catanzaro CZ, Italy. Email: [email protected]Search for more papers by this authorEugenio Arrighi, Eugenio Arrighi Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorFrancesca Serapide, Francesca Serapide Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorMaria Chiara Pelle, Maria Chiara Pelle Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorBruno Tassone, Bruno Tassone Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorRosaria Lionello, Rosaria Lionello Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorGiuseppina Marrazzo, Giuseppina Marrazzo Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorDomenico Laganà, Domenico Laganà Department of Experimental and Clinical Medicine, Radiodiagnostic Institute, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorFrancesco Saverio Costanzo, Francesco Saverio Costanzo Department of Experimental and Clinical Medicine, Research Center of Advanced Biochemistry and Molecular Biology, "Magna Grecia" University of Catanzaro, Catanzaro, Italy Department of Experimental and Clinical Medicine, CIS for Genomics and Molecular Pathology, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorGiovanni Matera, Giovanni Matera Department of Health Sciences, Institute of Microbiology, "Magna Grecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorEnrico Maria Trecarichi, Enrico Maria Trecarichi Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorCarlo Torti, Carlo Torti Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy Department of Health Sciences, Institute of Microbiology, "Magna Grecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this author Maria Mazzitelli, Corresponding Author Maria Mazzitelli [email protected] orcid.org/0000-0003-0263-0703 Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy Correspondence Maria Mazzitelli, MD, Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University, Viale Europa 22, 88100 Catanzaro CZ, Italy. Email: [email protected]Search for more papers by this authorEugenio Arrighi, Eugenio Arrighi Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorFrancesca Serapide, Francesca Serapide Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorMaria Chiara Pelle, Maria Chiara Pelle Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorBruno Tassone, Bruno Tassone Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorRosaria Lionello, Rosaria Lionello Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorGiuseppina Marrazzo, Giuseppina Marrazzo Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorDomenico Laganà, Domenico Laganà Department of Experimental and Clinical Medicine, Radiodiagnostic Institute, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorFrancesco Saverio Costanzo, Francesco Saverio Costanzo Department of Experimental and Clinical Medicine, Research Center of Advanced Biochemistry and Molecular Biology, "Magna Grecia" University of Catanzaro, Catanzaro, Italy Department of Experimental and Clinical Medicine, CIS for Genomics and Molecular Pathology, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorGiovanni Matera, Giovanni Matera Department of Health Sciences, Institute of Microbiology, "Magna Grecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorEnrico Maria Trecarichi, Enrico Maria Trecarichi Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this authorCarlo Torti, Carlo Torti Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy Department of Health Sciences, Institute of Microbiology, "Magna Grecia" University of Catanzaro, Catanzaro, ItalySearch for more papers by this author First published: 15 May 2020 https://doi.org/10.1002/jmv.26016Citations: 31Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Di Giambenedetto S, Ciccullo A, Borghetti A, et al. Off-label use of tocilizumab in patients with SARS-CoV-2 infection [published online ahead of print April 16, 2020]. J Med Virol. 2020. https://doi.org/10.1002/jmv.25897 PubMedWeb of Science®Google Scholar 2Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020; 1-5. https://doi.org/10.1002/jmv.25801 PubMedWeb of Science®Google Scholar 3Zhang X, Song K, Tong F, et al. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 2020; 4(7): 1307-1310. https://doi.org/10.1182/bloodadvances.2020001907 10.1182/bloodadvances.2020001907 CASPubMedWeb of Science®Google Scholar 4Michot JM, Albiges L, Chaput N, et al. Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report [published online ahead of print July, 2020]. Ann Oncol. 2020. https://doi.org/10.1016/j.annonc.2020.03.300 PubMedWeb of Science®Google Scholar 5Mihai C, Dobrota R, Schröder M, et al. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD. Ann Rheum Dis. 2020; 79(5): 668-669. https://doi.org/10.1136/annrheumdis-2020-217442 10.1136/annrheumdis-2020-217442 CASPubMedWeb of Science®Google Scholar 6Abdallah H, Hsu JC, Lu P, et al. Pharmacokinetic and pharmacodynamic analysis of subcutaneous tocilizumab in patients with rheumatoid arthritis from 2 randomized, controlled trials: SUMMACTA and BREVACTA. J Clin Pharmacol. 2017; 57(4): 459-468. https://doi.org/10.1002/jcph.826 10.1002/jcph.826 CASPubMedWeb of Science®Google Scholar 7Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws [published online ahead of print July, 2020]. Oral Oncol. 2020. https://doi.org/10.1016/j.oraloncology.2020.104659 PubMedWeb of Science®Google Scholar 8Morrison AR, Johnson JM, Ramesh M, Bradley P, Jennings J, Smith ZR. Letter to the editor: acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab [published online ahead of print April 21, 2020]. J Med Virol. 2020. https://doi.org/10.1002/jmv.25907 PubMedWeb of Science®Google Scholar Citing Literature Volume93, Issue1Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIIIJanuary 2021Pages 32-34 ReferencesRelatedInformation